Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

0.591
Delayed Data
As of Jun 24
 -0.0675 / -10.25%
Today’s Change
0.58
Today|||52-Week Range
2.50
-55.56%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.66
Today’s open0.64
Day’s range0.59 - 0.64
Volume13,049,633
Average volume (3 months)807,733
Market cap$92.0M
Dividend yield--
Data as of 06/24/2016

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+55.56%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.15%
P/E ratioNM
Price/Sales15.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...-0.01-3.66%
XENEXenon Pharmaceutical...+0.06+0.96%
CORICorium International...+0.06+1.50%
ASMBAssembly Biosciences...-0.24-4.23%
Data as of 06/24/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$13.2M
Annual profit (last year)-$27.6M
Net profit margin-213.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Operating Officer
Jed Andrew Latkin
Chief Scientific Officer &
Senior Vice President
Frederick O. Cope
Corporate headquarters
Dublin, Ohio

Forecasts

Partner Offers

Search for Jobs